上海萊士(002252.SZ):寧波科瑞金鼎被動減持公司1020萬股
格隆匯6月5日丨上海萊士(002252.SZ)公佈,科瑞天誠投資控股有限公司(“科瑞天誠”)一致行動人寧波科瑞金鼎投資合夥企業(有限合夥)(“寧波科瑞金鼎”)原質押給中鐵信託有限責任公司(“中鐵信託”)的1020萬股上海萊士血液製品股份有限公司(“上海萊士”)股票因逾期未按約定購回而構成違約。
鑑於前述情況,中鐵信託通過向人民法院申請強制執行方式對質押的標的證券進行違約處置。近日收到相關法院執行裁定書,原質押給中鐵信託的1020萬股上海萊士股票作價人民幣8639.4萬元,交付給中鐵信託以抵償相應的債務。上述1020萬股上海萊士股票已於2020年5月29日在中國證券登記結算有限責任公司完成司法過户手續,寧波科瑞金鼎因此被動減持上海萊士股份1020萬股(占上海萊士總股本的0.15%)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.